NEW YORK, Feb. 14, 2018 -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aerohive Networks, Inc. ("Aerohive " or the "Company") (NYSE:HIVE) and certain of its officers, on behalf of shareholders who purchased Aerohive securities during the period between November 1, 2017 and January 16, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/hive.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there were underlying sales execution issues that were uncovered at the end of the third quarter of 2017; (2) consequently, Aerohive’s revenue guidance for the fourth quarter of 2017 was overstated; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times.
On November 1, 2017, Aerohive held its third quarter 2017 conference call, when CFO, John Ritchie, said that “[w]e are currently expecting Q4 revenue in the range of $40 million to $42 million,” and that “[w]e realized significant sales efficiency with our non-GAAP sales and marketing costs.” Then, on January 16, 2018, Aerohive revealed that it “expects net revenue for the fourth quarter to be approximately $37 million, which is below the Company’s previously stated guidance of $40 million to $42 million.” Aerohive noted that the reduced guidance was due to “underlying sales execution issues” revealed at the end of its third quarter. Following this news, Aerohive stock dropped $1.63 per share or over 29% to close at $4.07 per share on January 17, 2018.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/hive or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aerohive you have until March 20, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]


How Marco Pharma International Preserves German Homeopathic Traditions in America
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



